Authors/Disclosures
|
Carlos Henrique F. Camargo, MD, PhD, MSc, FAAN
(Inovare Serviços de Saude Ltda.)
|
Dr. Camargo has nothing to disclose. |
|
David C. Squillacote, MD
(David Squillacote MD)
|
No disclosure on file |
|
Anna V. Levit, PharmD
(Acorda Therapeutics)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Connie C. Marras, MD
(Toronto Western Hospital)
|
Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene. |
|
Hubert H. Fernandez, MD, FAAN
(Center for Neurological Restoration, Cleveland Clinic)
|
Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Fernandez has received research support from Biogen. The institution of Dr. Fernandez has received research support from Michael J Fox Founda. The institution of Dr. Fernandez has received research support from Roche. The institution of Dr. Fernandez has received research support from Parkinson Foundation. The institution of Dr. Fernandez has received research support from UCB. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group. |